Drugdiscovery >> Pharmaceutical Companies >> News
4685
Views
Bayer and Compugen signed a deal - drugdiscovery.com
Bayer and Compugen signed a deal - drugdiscovery.com


The collaboration centres around the development of antibody-based therapeutics for cancer immunotherapy.
Read More >>


Tags: collaboration, Bayer, Compugen, cancer immunotherapy - August 7, 2013
Related Articles
5357
Views
Sanofi - Pozen deal Sanofi - Pozen deal
The two companies agreed that Sanofi handles U.S. marketing of Pozen’s experimental cardiovascular drugs PA8140 and PA32540, intended as an alternative to aspirin as a secondary treatment for the pr Read More >>

Tags: Sanofi, Pozen, deal, agreement, US marketing, experimental cardiovascular drugs, PA8140, PA32540

4331
Views
  Bayer added to the crowd of companies under Chinese investigation Bayer added to the crowd of companies under Chinese investigation
As China aims to bring its healthcare costs under control, there is another foreign pharmaceutical company under the investigation of Chinese authorities. Read More >>

Tags: Bayer, news, China, investigation

4924
Views
AbbVie’s cystic fibrosis deal AbbVie’s cystic fibrosis deal
AbbVie enters into collaboration with Dutch drug developer Galapagos NV with the aim to study treatments for cystic fibrosis. The deal could be worth more than $405 million to Galapagos. Read More >>

Tags: AbbVie, Galapagos, cystic fibrosis, deal

2323
Views
Bayer is told to acquire algeta Bayer is told to acquire algeta
Algeta is planning to stabilize its role in the oncology market. The company is now acquiring a Norwegian pharmaceutical company, Algeta. Read More >>

Tags: Algeta, Bayer, oncology

4144
Views
Bayer – Broad Institute alliance Bayer – Broad Institute alliance
Bayer Health Care and Broad Institute in Cambridge, Mass. , one of the world’s most renowned non-profit biomedical research institutes , have signed a collaboration agreement to jointly discover and Read More >>

Tags: Bayer, cancer therapeutics, collaboration, alliance, Broad Institute

6647
Views
Merck, AstraZeneca ovarian cancer drug deal Merck, AstraZeneca ovarian cancer drug deal
AstraZeneca will take over from Merck the clinical development of a potential ovarian cancer treatment , MK-1775, which is in mid-stage clinical testing as a possible oral treatment for certain form Read More >>

Tags: Merck, AstraZeneca, deal, ovarian cancer, drug, development

3185
Views
Astra Zeneca has signed a contract with the South Korean Government Astra Zeneca has signed a contract with the South Korean Government
A memorandum of understanding was signed by AstraZeneca and South Korean government. Korea guarantees to help some early-stage drug development projects. Read More >>

Tags: AstraZeneca, research, South Korea, memorandum of understanding

2991
Views
Illumina has signed contract Illumina has signed contract
Illumina has signed a contract with NextBio, a bioinformatics company, which has made an enormous research towards Big Data processing. Wit the contribution, Illumina hopes to be able to serve its cos Read More >>

Tags: genoma, data, big data, Illumina, NextBio

949
Views
Charles River Laboratories International signed a new contract Charles River Laboratories International signed a new contract
Charles River Laboratories International has entered in a contract with Argenta and BioFocus. This trade is going to be one of the most profitable investments for all the companies. Read More >>

Tags: Drug discovery, Charles River Laboratories International. BioFocus, Argenta, contract

3656
Views
The top respected pharma brand in the US The top respected pharma brand in the US
According to the latest "BrandPower Ranking" Bayer, a german chemical and pharmaceutical company, was ranked fifth among the 100 best-known and most popular brands in the US, but first among pharmaceu Read More >>

Tags: Bayer, ranking, top, respected, pharmaceutical company, most popular, brand

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013